Jung Cassie — SEC Form 4 filings
SEC reporting owner CIK 1960154. 11 Form 4 filings on record with FilingPulse; latest filed 2026-09-08.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-03-11 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 175,590 shares, $975,901 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: sale of 67,575 shares @ $7.01 ($473,701) in Aquestive Therapeutics, Inc., filed 2025-10-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | Chief Operating Officer | 11 | — | 4 legs · 175,590 sh · $975,901 | 23 |
Form 4 filings — Jung Cassie
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-08 | 4 | Aquestive Therapeutics, Inc. (AQST) | Option exercise/expiry (X): 4,587 @ $0.96 · Option exercise/expiry (X): 4,587 (derivative) @ $0 | EDGAR |
| 2026-05-07 | 4 | Aquestive Therapeutics, Inc. (AQST) | Tax withholding (F): 72,734 @ $4.18 | EDGAR |
| 2026-04-13 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 80,000 @ $0 · Sale (S): 45,791 @ $4.17 · Grant/award (A): 42,500 (derivative) @ $0 | EDGAR |
| 2025-10-17 | 4 | Aquestive Therapeutics, Inc. (AQST) | Option exercise (M): 25,000 @ $3.10 · Sale (S): 67,575 @ $7.01 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2025-09-08 | 4 | Aquestive Therapeutics, Inc. (AQST) | Option exercise (M): 25,000 @ $3.15 · Option exercise (M): 25,000 @ $0.71 · Sale (S): 62,180 @ $5 · Option exercise (M): 25,000 (derivative) @ $0 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 80,000 @ $0 · Tax withholding (F): 7,361 @ $2.65 · Tax withholding (F): 7,997 @ $2.65 · Tax withholding (F): 2,182 @ $2.54 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-11-27 | 4 | Aquestive Therapeutics, Inc. (AQST) | Sale (S): 44 @ $4.87 | EDGAR |
| 2024-10-02 | 4/A | Aquestive Therapeutics, Inc. (AQST) | Tax withholding (F): 14,120 @ $4.88 | EDGAR |
| 2024-03-12 | 4 | Aquestive Therapeutics, Inc. (AQST) | Tax withholding (F): 8,300 @ $4.88 · Tax withholding (F): 1,132 @ $4.88 | EDGAR |
| 2024-03-11 | 4 | Aquestive Therapeutics, Inc. (AQST) | Tax withholding (F): 1,365 @ $0 · Grant/award (A): 101,250 @ $0 · Grant/award (A): 50,625 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1960154 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →